Familial Amyloid Polyneuropathy: Receptor for Advanced Glycation End Products-Dependent Triggering of Neuronal Inflammatory and Apoptotic Pathways

The biochemistry of apoptosis

Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012

RAGE Mediates a Novel Proinflammatory Axis

Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,506

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431

Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239

The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin

Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151

Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models

Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086

Familial and Senile Amyloidosis Caused by Transthyretin

Zeldenrust, S. R., & Benson, M. D. (2010) · doi:10.1002/9780470572702.ch36 · Cited by 25

Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-κB activation

Matsunaga, N., Anan, I., Forsgren, S., Nagai, R., Rosenberg, P. M., Horiuchi, S., Ando, Y., & Suhr, O. B. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0574-0 · Cited by 24

MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy

Martins, D. F., Moreira, J., Gonçalves, N. P., & Saraiva, M. J. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028571 · Cited by 24

Extracellular Matrix Markers for Disease Progression and Follow‐Up of Therapies in Familial Amyloid Polyneuropathy V30M TTR‐Related

Cardoso, I., Brito, M. A., & Saraiva, M. J. (2008) · Disease Markers · doi:10.1155/2008/549872 · Cited by 25

Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures

Kurian, S. M., Novais, M., Whisenant, T. C., Gelbart, T., Buxbaum, J. N., Kelly, J. W., Coelho, T., & Salomon, D. R. (2016) · Theranostics · doi:10.7150/thno.14584 · Cited by 22

Transthyretin Aggregates Induce Production of Reactive Nitrogen Species

Fong, V. H., & Vieira, A. V. (2012) · Neurodegenerative Diseases · doi:10.1159/000338153 · Cited by 21

Peripheral and Autonomic Nervous Systems

Deshpande, S., Rafique, M. B., & Vanga, N. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199381623.003.0021 · Cited by 21

Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis

Nuvolone, M., & Merlini, G. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1398235 · Cited by 20

Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin

Suenaga, G., Ikeda, T., Masuda, T., Motokawa, H., Yamashita, T., Takamatsu, K., Misumi, Y., Ueda, M., Matsui, H., Senju, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01775-4 · Cited by 20

Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice

Park, S. M., Shin, J. H., Moon, G. J., Cho, S. I., Lee, Y. B., & Gwag, B. J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-106 · Cited by 19

Treatment of hereditary and acquired forms of transthyretin amyloidosis in the era of personalized medicine: the role of randomized controlled trials

Buxbaum, J. N. (2019) · Amyloid · doi:10.1080/13506129.2019.1575201 · Cited by 19

Impairment of the ubiquitin–proteasome system associated with extracellular transthyretin aggregates in familial amyloidotic polyneuropathy

Santos, S. D., Cardoso, I., Magalhães, J., & Saraiva, M. J. (2007) · The Journal of Pathology · doi:10.1002/path.2224 · Cited by 18

Amyloid: Morphology and Toxicity

Olofsson, A., Östman, J., & Lundgren, E. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.219 · Cited by 19

147th ENMC International Workshop: Guideline on processing and evaluation of sural nerve biopsies, 15–17 December 2006, Naarden, The Netherlands

Sommer, C., Brandner, S., Dyck, P. J. B., Magy, L., Mellgren, S. I., Morbin, M., Schenone, A. E., Tan, E., & Weis, J. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.08.010 · Cited by 19

Advanced glycation end products induce death of retinal neurons via activation of nitric oxide synthase

Kobayashi, T., Oku, H., Komori, A., Okuno, T., Kojima, S., Obayashi, H., Sugiyama, T., Hasegawa, G., Fukui, M., Nakamura, N., et al. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.04.001 · Cited by 18

Familial Amyloidotic Polyneuropathy: Protein Aggregation in the Peripheral Nervous System

Saraiva, M. J., Sousa, M. M., Cardoso, I., & Fernandes, R. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:1-2:035 · Cited by 18

Deletion of Receptor for Advanced Glycation End Products Exacerbates Lymphoproliferative Syndrome and Lupus Nephritis in B6-MRL Fas lpr/j Mice

Goury, A., Meghraoui, A., Belmokhtar, K., Vuiblet, V., Ortillon, J., Jaisson, S., Devy, J., Naour, R. L., Tabary, T., Cohen, J. H. M., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402342 · Cited by 17

αB‐crystallin (HspB5) in familial amyloidotic polyneuropathy

Magalhães, J., Santos, S. D., & Saraiva, M. J. (2010) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2010.00735.x · Cited by 16

Evidence of Oxidative Stress in Familial Amyloidotic Polyneuropathy Type 1

Fiszman, M. L., Egidio, M. D., Ricart, K. C., Repetto, M. G., Borodinsky, L. N., Llesuy, S., Saizar, R. D., Trigo, P. L., Riedstra, S., Costa, P., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.593 · Cited by 16

Cell Interaction Study of Amyloid by Using Luminescent Conjugated Polythiophene: Implication that Amyloid Cytotoxicity Is Correlated with Prolonged Cellular Binding

Zako, T., Sakono, M., Kobayashi, T., Sörgjerd, K. M., Nilsson, K. P. R., Hammarström, P., Lindgren, M., & Maeda, M. (2012) · ChemBioChem · doi:10.1002/cbic.201100467 · Cited by 15

Activation of the Heat Shock Response in Familial Amyloidotic Polyneuropathy

Santos, S. D., Magalhães, J., & Saraiva, M. J. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816fd648 · Cited by 15

Hereditary transthyretin amyloidosis (ATTRv)

Triposkiadis, F. K., Briasoulis, Α., Starling, R. C., Magouliotis, D. E., Kourek, C., Zakynthinos, G. Ε., Iliodromitis, E. K., PARASKEVAIDIS, I. A., & Xanthopoulos, A. V. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103019 · Cited by 15

Long-Term Outcomes and Complications of Trabeculectomy for Secondary Glaucoma in Patients with Familial Amyloidotic Polyneuropathy

Kawaji, T., Inoue, T., Hara, R., Eiki, D., Ando, Y., & Tanihara, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096324 · Cited by 14

Glial cells in familial amyloidotic polyneuropathy

Gonçalves, N. P., Costelha, S., & Saraiva, M. J. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0177-8 · Cited by 15

Mechanisms of Transthyretin Aggregation and Toxicity

Gasperini, R., Klaver, D. W., Hou, X., Aguilar, M., & Small, D. H. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4_9 · Cited by 14

Pro-oxidative effects of aggregated transthyretin in human Schwannoma cells

Fong, V. H., & Vieira, A. V. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.08.013 · Cited by 14

Multi-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients

Susuki, S., Ando, Y., Sato, T., Nishiyama, M., Miyata, M., Suico, M. A., Shuto, T., & Kai, H. (2008) · Amyloid · doi:10.1080/13506120802006013 · Cited by 14

Kidney Transplantation in Systemic Amyloidosis

Angel-Korman, A., & Havasi, A. (2020) · Transplantation · doi:10.1097/tp.0000000000003170 · Cited by 14

Emerging Roles for Dendritic Cells in Heart Failure

Saleh, D., Jones, R., Schroth, S. L., Thorp, E. B., & Feinstein, M. J. (2023) · Biomolecules · doi:10.3390/biom13101535 · Cited by 14

Transthyretin Amyloidosis: Role of oxidative stress and the beneficial implications of antioxidants and nutraceutical supplementation

Eze, F. N. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105837 · Cited by 14

Protective Role of Anakinra Against Transthyretin-Mediated Axonal Loss and Cell Death in a Mouse Model of Familial Amyloidotic Polyneuropathy

Gonçalves, N. P., Teixeira‐Coelho, M., & Saraiva, M. J. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000164 · Cited by 12

Cellular consequences of transthyretin deposition

Saraiva, M. J. (2003) · Amyloid · doi:10.1080/13506129.2003.12088562 · Cited by 12

Pathophysiology of Cardiac Amyloidosis

Morfino, P., Aimo, A., Franzini, M., Vergaro, G., Castiglione, V., Panichella, G., Limongelli, G., & Emdin, M. (2024) · Heart Failure Clinics · doi:10.1016/j.hfc.2024.02.002 · Cited by 11

Oligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3B

Moreira, L., Beirão, J. M., Beirão, I. B., & Costa, P. (2015) · Amyloid · doi:10.3109/13506129.2015.1007497 · Cited by 11

Targeting a rare amyloidotic disease through rationally designed polymer conjugates

Conejos‐Sánchez, I., Cardoso, I., Saraiva, M. J., & Vicent, M. J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.01.019 · Cited by 11

Chapter 41 Painful small-fiber neuropathies

Sommer, C., & Lauria, G. (2006) · Handbook of clinical neurology · doi:10.1016/s0072-9752(06)80045-x · Cited by 11

Hereditary Amyloid Neuropathy

Reilly, M. M. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50086-7 · Cited by 11

Nerve pathology of microangiopathy and thromboinflammation in hereditary transthyretin amyloidosis

Yeh, S., Yeh, T., Wang, Y., Chao, C., Tzeng, S., Tang, T., Hsieh, J., Kan, Y., Yang, W., & Hsieh, S. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51930 · Cited by 10

Skeletal muscle involvement in systemic amyloidosis is often overlooked

Xu, J., Zhou, X., Wang, Y., Liu, W., Shan, Y., Zhang, D., Lv, H., Zhao, D., Dai, T., Zhao, Y., et al. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12996 · Cited by 10

Aqueous humor erythropoietin levels in open-angle glaucoma patients with and without TTR V30M familial amyloid polyneuropathy.

Beirão, J. M., Moreira, L., Oliveira, J. C. F., Menéres, M. J., Pessoa, B., Matos, M. E., Costa, P., Torres, P., & Beirão, I. B. (2014) · Europe PMC (PubMed Central) · Cited by 10

Use of Noninvasive Imaging in Cardiac Amyloidosis

Quintana-Quezada, R. A., Yusuf, S. W., & Banchs, J. A. (2016) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-016-0469-3 · Cited by 10

Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?

Bellofatto, I. A., Nikolaou, P., Andreadou, I., Canepa, M., Carbone, F., Ghigo, A., Heusch, G., Kleinbongard, P., Maack, C., Podesser, B. K., et al. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02522-2 · Cited by 9

Overexpression of Protocadherin-10 in Transthyretin-Related Familial Amyloidotic Polyneuropathy

Gonçalves, N. P., Martins, D. F., & Saraiva, M. J. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.02.020 · Cited by 9

A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy

Murakami, T., Yokoyama, T., Mizuguchi, M., Toné, S., Takaku, S., Sango, K., Nishimura, H., Watabe, K., & Sunada, Y. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15162 · Cited by 9

Amyloid and the Heart

Wolfson, A., Shah, K., & Patel, J. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1230-9 · Cited by 10

Transthyretin variants impact blood–nerve barrier and neuroinflammation in amyloidotic neuropathy

Chao, C., Yang, W., Yeh, T., Kan, Y., Wang, Y., Lee, K.-J., Hu, C.-J., Tang, T., Ide, T., Hsueh, H., et al. (2025) · Brain · doi:10.1093/brain/awaf028 · Cited by 8

Neurodegeneration in familal amyloidotic polyneuropathy

Gasperini, R., & Small, D. H. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05607.x · Cited by 8

Effect of lysine modification on the stability and cellular binding of human amyloidogenic light chains

Davern, S. M., Murphy, C. L., O’Neill, H., Wall, J. S., Weiss, D. T., & Solomon, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.022 · Cited by 8

Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy

Fella, E., Sokratous, K., Papacharalambous, R., Kyriacou, K. C., Phillips, J. A., Sanderson, S. D., Panayiotou, E., & Kyriakides, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00138 · Cited by 8

Tissue remodeling after interference RNA mediated knockdown of transthyretin in a familial amyloidotic polyneuropathy mouse model

Gonçalves, N. P., Gonçalves, P., Magalhães, J., Ventosa, M., Coelho, A. V., & Saraiva, M. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.020 · Cited by 9

Cytotoxic Effects of Transthyretin Aggregates in an Epidermoid Cell Line

Fong, V. H., & Vieira, A. V. (2017) · Pathobiology · doi:10.1159/000466701 · Cited by 7

Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to influence the polyol pathway

Ruf, T. F., Quintes, S., Sternik, P., & Göttmann, U. (2009) · Clinical and investigative medicine · doi:10.25011/cim.v32i3.6111 · Cited by 7

Serum Inflammatory Profile in Hereditary Transthyretin Amyloidosis: Mechanisms and Possible Therapeutic Implications

Luigetti, M., Romano, Â., Guglielmino, V., Sciarrone, M. A., Vitali, F., Carbone, C., Piro, G., Sabino, A., Stefano, N. D., Plantone, D., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12121708 · Cited by 6

Cardiac amyloidosis induces up-regulation of Deleted in Malignant Brain Tumors 1 (DMBT1)

Müller, H., Renner, M., Bergmann, F., Mechtersheimer, G., Weiß, C., Poeschl, J., Helmke, B. M., & Mollenhauer, J. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.10.006 · Cited by 6

Insights into the pharmaceuticals and mechanisms of neurological orphan diseases: Current Status and future expectations

Ramalho, T. C., de Castro, A. A., Tavares, T. S., Silva, M. D. C., Silva, D. R., Cesar, P. H., Santos, L. D. A., da Cunha, E. F. F., Nepovimová, E., & Kuča, K. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.011 · Cited by 6

Interactions of Lipid Membranes with Fibrillar Protein Aggregates

Gorbenko, G. P., Trusova, V. M., Girych, M., Adachi, E., Mizuguchi, C., & Saito, H. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17344-3_6 · Cited by 6

Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis

Plantone, D., Primiano, G., Righi, D., Romano, Â., Luigetti, M., & Stefano, N. D. (2023) · Cells · doi:10.3390/cells12192383 · Cited by 5

Experimental and hypothetical appraisal on inhibition of glucose-induced glycation of bovine serum albumin by quercetin

Oso, B. J., Olaoye, I. F., & Oso, O. T. (2023) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-023-00588-5 · Cited by 5

Toxicity of Protein and DNA-AGEs in Neurodegenerative Diseases (NDDs) with Decisive Approaches to Stop the Deadly Consequences

Akhter, F., Akhter, A., & Ahmad, S. (2017) · Environmental science and engineering · doi:10.1007/978-3-319-46248-6_5 · Cited by 5

The Role of Inflammation in Amyloid Diseases

Azevedo, E. P., & Foguel, D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81888 · Cited by 7

The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis

Moreira, J., Costelha, S., Saraiva, M., & Saraiva, M. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650269 · Cited by 4

Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study

Luigetti, M., Vitali, F., Romano, Â., Sciarrone, M. A., Guglielmino, V., Ardito, M., Sabino, A., Servidei, S., Piro, G., Carbone, C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69123-x · Cited by 4

Human TTRV30M localization within podocytes in a transgenic mouse model of transthyretin related amyloidosis: does the environment play a role?

Petrakis, I., Mavroeidi, V., Stylianou, K., Efthymiou, G., Perakis, K., Vardaki, E., Stratigis, S., Giannakakis, K., Kourouniotis, K., Amoiridis, G., et al. (2012) · Transgenic research · doi:10.1007/s11248-012-9632-0 · Cited by 4

The effect of lysozyme amyloid fibrils on cytochrome c–lipid interactions

Gorbenko, G. P., Trusova, V. M., Sood, R., Molotkovsky, J. G., & Kinnunen, P. K. J. (2012) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2012.10.001 · Cited by 4

Transthyretin in Peripheral Nerve Regeneration

Mar, F. M., Franquinho, F., Fleming, C. E., & Sousa, M. M. (2009) · Future Neurology · doi:10.2217/fnl.09.50 · Cited by 4

Effect of MPO/H2O2/NO- system on nitric oxide-mediated modification of TTR amyloid and serum TTR in FAP ATTR Val30Met patients

Liu, J., Wang, Q. Y., Zheng, F., Jin-hai, L., Ge, P., Gu, Y., & Sun, X. (2014) · Genetics and Molecular Research · doi:10.4238/2014.april.3.9 · Cited by 4

Upregulation of the Extracellular Matrix Remodeling Genes, Biglycan, Neutrophil Gelatinase-Associated Lipocalin and Matrix Metalloproteinase-9 in Familial Amyloid Polyneuropathy

Saraiva, M. J., Guimarães, A., Sousa, M. M., & do Amaral, B. (2004) · CRC Press eBooks · doi:10.1201/9781420037494.ch109 · Cited by 4

Rac1 inhibition prevents axonal cytoskeleton dysfunction in transthyretin amyloid polyneuropathy

Magalhães, J., Dias, V. P., Eira, J., da Silva, M. I. O., Nóvoa, G., Martins, M., Kan, H., Dias, A., Carvalho, E., Santos, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116411 · Cited by 3

TLR2 and 4 signaling pathways are altered in macrophages from V30M TTR mice with down-regulated expression of chemokines

Moreira, J., Martins, H., Saraiva, M., & Saraiva, M. J. (2023) · Clinical Science · doi:10.1042/cs20220656 · Cited by 3

Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis

Petrakis, I., Mavroeidi, V., Stylianou, K., Andronikidi, E., Lioudaki, E., Perakis, K., Stratigis, S., Vardaki, E. A., Zafeiri, M., Giannakakis, K., et al. (2013) · Amyloid · doi:10.3109/13506129.2013.814046 · Cited by 3

Transthyretin

Damas, A. M., & Saraiva, M. J. (2005) · doi:10.1002/9783527619344.ch21 · Cited by 3

Abstracts from the First European Meeting for ATTR Amyloidosis for Doctors and Patients

(2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0710-5 · Cited by 3

Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptors

Zhang, C., He, Y., Liu, X., Xie, J., Fang, M., Yang, X., Huang, R., Lou, Q., Li, B., Gupta, A., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02462-x · Cited by 2

Profibrotic Biomarkers Correlate with Clinical Presentation and Outcome in Cardiac Transthyretin Amyloidosis

Hein, S. J., Siepen, F. A. D., Kristen, A. V., Schönland, S. O., Hegenbart, U., Rein, K., Katus, H. A., Frey, N., Furkel, J., Konstandin, M. H., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110714 · Cited by 2

Clinical differences between transthyretin cardiac amyloidosis and hypertensive heart disease

Fernández, I. G., Aguilera, J. L., Manzanares, R. G., Pericet-Rodríguez, C., Carmona-Rico, M. J., Armijo, J. P., Castillo-Dominguez, J. C., & Anguita-Sánchez, M. P. (2024) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2023.10.011 · Cited by 2

Expression of the Transthyretin Gene in Schwann Cells and Familial Amyloidotic Polyneuropathy-Mediated Neurodegeneration

Murakami, T., & Sunada, Y. (2014) · Springer eBooks · doi:10.1007/978-4-431-54764-8_7 · Cited by 2

Pathogenesis of Systemic Amyloidoses

Lavatelli, F., Palladini, G. O., & Merlini, G. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-631-3_4 · Cited by 2

Teaching an Old Dog New Tricks

Kalra, D. K. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.06.016 · Cited by 2

Decreased expression of S100A8/A9 in V30M related ATTRv amyloidosis

Moreira, J., Martins, S., Saraiva, M., & Saraiva, M. J. (2023) · Amyloid · doi:10.1080/13506129.2023.2185755 · Cited by 2

From pathophysiology to treatment in transthyretin cardiac amyloidosis.

Correia-Rodrigues, Â., Ribeiro-Rodrigues, T. M., Gonçalves, L., Almeida, J., Ferreira, M. J., & Girão, H. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.07.002 · Cited by 1

Activities of apocynin in cytotoxicity assays of potential pathological relevance

Wong, S. P., Fong, V. H., & Vieira, A. V. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.10.007 · Cited by 1

Diferencias clínicas entre la amiloidosis cardiaca por transtirretina y la cardiopatía hipertensiva

Fernández, I. G., Aguilera, J. L., Manzanares, R. G., Pericet-Rodríguez, C., Carmona-Rico, M. J., Armijo, J. P., Castillo-Dominguez, J. C., & Anguita-Sánchez, M. P. (2023) · Medicina Clínica · doi:10.1016/j.medcli.2023.10.006 · Cited by 1

Transthyretin Aggregation and Toxicity

Saraiva, M. J., & Cardoso, I. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_13 · Cited by 1

The Clone Wars: Diagnosing and Treating Dysproteinemic Kidney Disease in the Modern Era

Avasare, R. S., Andeen, N. K., Havasi, A., & Hogan, J. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081633 · Cited by 1

Renal Amyloidosis

Dember, L. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-631-3_9 · Cited by 1

Pathology of human diabetic neuropathy

Mojaddidi, M. A., Sharma, A., & Malik, R. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch63 · Cited by 1

Role of the 39-kDa receptor-associated protein (RAP) in Alzheimer's disease

Hoang, T. (2012) · UTAS Research Repository · doi:10.25959/23206328

Molecular Pathogenesis Associated with Familial Amyloidotic Polyneuropathy

Saraiva, M. J. (2009) · Springer eBooks · doi:10.1007/978-3-642-00646-3_12

Effects of physiological, pharmacological, and toxic factors on cell transport

Wong, S. P. (2014) · Summit (Simon Fraser University)

A Drosophila Disease-Model for Transthyretin-associated Amyloidosis

Pokrzywa, M. (2008) · Diva portal (Dalarna University Library)

MOLECULAR AND CELLULAR STUDIES OF TRANSTHYRETIN AND RELATED AMYLOID PATHOGENESIS

Fong, V. H. (2011) · Summit (Simon Fraser University)

Targeting cytotoxic species in amyloid diseases

Persson, M. (2012)

The mouse as a model to understand peroxisomal disorders

Brites, P. (2009) · UvA-DARE (University of Amsterdam)

Contemporary Reviews in Cardiovascular Medicine Transthyretin (TTR) Cardiac Amyloidosis

Ruberg, F. L., John, M., & Berk, L. (2016)

L'amylose cardiaque à transthyrétine (TTR)

Ruberg, F. L., & Berk, J. L. (2012)

Efeito do fibrinogénio na formação de fibras de TTR em doentes com amiloidose familiar

Ciências, F. D. (2011)

Modificações pós-traducionais de proteínas na amiloidogénese: Glicação e agregação da transtirretina in vivo em Saccharomyces cerevisiae.

Ciências, F. D. (2008)

Other Hereditary Neuropathies

Li, J. (2005) · Neurological disease and therapy · doi:10.1201/b14157-28

Selection of transthyretin amyloid inhibitors

Iakovleva, I. (2016) · DiVA at Umeå University (Umeå University)

The role of RAGE in the diabetic neuropathy

Juranek, J. K., & Banach, M. D. (2015) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr/60316

Prenatal sex and race determination is a slippery slope: author’s reply

Dickens, B. M. (2004) · Journal of Medical Ethics · doi:10.1136/jme.2003.006478

Interaction of the Receptor for Advanced Glycation End Products (RAGE) with Transthyretin Triggers Nuclear Transcription Factor kB (NF-kB) Activation

Sousa, M. M., Yan, S. D., Stern, D. M., & Saraiva, M. J. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780116 · Cited by 176

Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling

Sousa, M. M., & Saraiva, M. J. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.11.002 · Cited by 132

Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-κB activation

Matsunaga, N., Anan, I., Forsgren, S., Nagai, R., Rosenberg, P. M., Horiuchi, S., Ando, Y., & Suhr, O. B. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0574-0 · Cited by 24

Inflammation and Apoptotic Pathways in the Peripheral Nervous System Related to Protein Misfolding

Saraiva, M. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_12